Comparison of Effectiveness of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Ischemic Cardiomyopathy

American Journal of Cardiology

Volumn 99, Issue 1, 2007, Pages 36-41

  Buszman, Paweł ^a   Szkróbka, Iwona ^a   Gruszka, Agata ^a   Parma, Radosław ^a   Tendera, Zofia ^a   Leśko, Blanka ^a   Wilczyński, Mirosław ^a   Bochenek, Tomasz ^a   Wojakowski, Wojciech ^a   Bochenek, Andrzej ^a   Tendera, Michał ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EXERCISE; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DECISION TREES; DISEASE-FREE SURVIVAL; FEMALE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLAND; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME;

EID: 33845694638     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.056     Document Type: Article

References (13)

1. Sedlis S.P., Ramanathan K.B., Morrison D.A., Sethi G., Sacks J., Henderson W., Department of Veterans Affairs Cooperative Study, and Angina With Extremely Serious Operative Mortality Evaluation (AWSOME) Investigators. Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). Am J Cardiol 94 (2004) 118-120
2. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., Tavazzi L., Smiseth O.A., Gavazzi A., Haverich A., et al., The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure (update 2005). Eur Heart J 26 (2005) 19-28
3. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., et al. Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
4. Bax J.J., Poldermans D., and Elhendy A. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 34 (1999) 163-169
5. Rizzello V., Poldermans D., Boersma E., Biagini E., Kerati M.D., Schinkel A.F., Krenning B., Elhendy A., Vourvouri E.C., Sozzi F.B., et al. Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy. Circulation 110 (2004) 2383-2388
6. Leon M.B., Baim D.S., Popma J.J., Gordon P.C., Cutlip D.E., Ho K.K., Giambartolomei A., Diver D.J., Lasorda D.M., Wiliams D.O., et al., Stent Anticoagulation Restenosis Study Investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 339 (1998) 1665-1671
7. Pache J., Kastrati A., Mehilli J., Gawaz M., Neumann F.J., Seyfarth M., Hall D., Braun S., Dirschinger J., and Schomig A. Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen. Catheter Cardiovasc Interv 55 (2002) 436-441
8. Mazur W., Kaluza G.L., Sapp S., Balog C., Topol E.J., Mark D.B., Ellis S.G., Kereiakes D.J., Lincoff A.M., and Kleiman N.S. Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. Am Heart J 143 (2002) 594-601
9. Neumann F.J., and Schomig A. Glycoprotein IIb/IIIa receptor blockade with coronary stent placement. Semin Interv Cardiol 3 (1998) 81-90
10. Rodriguez A., Rodriguez Alemparte M., Baldi J., Navia J., Delacasa A., Vogel D., Oliveri R., Fernandez Pereira C., Bernardi V., O'Neill W., and Palacios I.F. Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study. Heart 89 (2003) 184-188
11. Serruys P.W., Unger F., Sousa J.E., Jatene A., Bonnier H.J., Schonberger J.P., Buller N., Bonser R., van den Brand M.J., et al., Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124
12. Morrison D.A., Sethi G., Sacks J., Henderson W.G., Grover F., Sedlis S., Esposito R., Investigator of the Department of Veterans Affairs Cooperative Study, and Angina With Extremely Serious Operative Mortality Evaluation. Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol 39 (2002) 266-273
13. Higgins T.L., Estafanous F.G., Loop F.D., Beck G.J., Blum J.M., and Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 267 (1992) 2344-2348